BCG in the immunotherapy of non-Hodgkin's malignant lymphomas: preliminary results of a controlled trial

Recent Results Cancer Res. 1978;65:160-3. doi: 10.1007/978-3-642-81249-1_19.

Abstract

Thirty-three patients exhibiting non-Hodgkin's malignant lymphoma with one or more criteria of poor prognosis and in whom complete remission had been induced by an association of chemo + radio + chemotherapy were randomized to either receive BCG or no further treatment. The present results indicate that BCG may be useful to maintain remission in about one-third of the patients, but these results are not yet significant.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • BCG Vaccine / therapeutic use*
  • Clinical Trials as Topic
  • Drug Therapy, Combination
  • Humans
  • Lymphoma / therapy*
  • Middle Aged
  • Remission, Spontaneous

Substances

  • Antineoplastic Agents
  • BCG Vaccine